Cell based assays

Are your cell-based assay leads physiologically relevant?

Current trends in drug discovery are driving the need for more disease-relevant assays. The BIND Reader enables label-free measurement of the functional response of endogenous cellular targets in most cell types, including primary cells.

Benefits of BIND® for Cell-based Screening

UNIVERSAL PLATFORM compatible with adherent and suspension cell types
PHYSIOLOGICALLY RELEVANT measurement of cellular pathway mechanism of response for endogenous targets
INCREASED EFFICIENCY in your drug discovery process

The BIND system takes advantage of its ability to detect changes in cell morphology or adherence in the proximity of the biosensor surface. BIND provides physiologically relevant assays in a broad range of formats, mechanism-based lead selection in screening, and increased efficiency in your drug discovery process.

The BIND system is comprised of the BIND Reader and 96-, 384- or 1536-well microplate biosensors that can easily be integrated into an automated workflow. There is no need for long equilibration times to stabilize assay signal. The open reader design facilitates rapid offline liquid addition followed by prompt measurement of cell response.

1 | 2 | 3 | 4



Applications Products Technology Company Management Team & Board of Directors News Employment Company Overview Technology Overview Publications Products Overview BIND® Reader • Software • Specifications BIND® Biosensor Download Literature ComBIND™ Microarray Slide Applications Overview Cell based assays Direct binding small molecule assays Antibody screening


Cell based assays Are your cell-based assay leads physiologically relevant? Current trends in drug discovery are driving the need for more disease-relevant assays. The BIND Reader enables label-free measurement of the functional response of endogenous cellular targets in most cell types, including primary cells. Benefits of BIND® for Cell-based Screening UNIVERSAL PLATFORM compatible with adherent and suspension cell types PHYSIOLOGICALLY RELEVANT measurement of cellular pathway mechanism of response for endogenous targets INCREASED EFFICIENCY in your drug discovery process The BIND system takes advantage of its ability to detect changes in cell morphology or adherence in the proximity of the biosensor surface. BIND provides physiologically relevant assays in a broad range of formats, mechanism-based lead selection in screening, and increased efficiency in your drug discovery process. The BIND system is comprised of the BIND Reader and 96-, 384- or 1536-well microplate biosensors that can easily be integrated into an automated workflow. There is no need for long equilibration times to stabilize assay signal. The open reader design facilitates rapid offline liquid addition followed by prompt measurement of cell response.
1 \| 2 \| 3 \| 4
Company \| Technology \| Products \| Applications \| Contact Us © 2000-2008 SRU Biosystems, Inc.